Patients see fewer asthma exacerbations with lebrikizumab
Patients with asthma exacerbations and elevated blood eosinophils and fractional exhaled nitric oxide saw fewer exacerbations with lebrikizumab, according to a study published in the Journal of Allergy and Clinical Immunology: In Practice.The safety profiles for adults and adolescents across the treatment groups were similar as well, Jonathan Corren, MD, associate clinical professor of medicine